Drug Price Trends for HUMATROPE

Average Pharmacy Cost for HUMATROPE

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
HUMATROPE 12 MG CARTRIDGE	00002-8148-01	1797.84600	EACH	2024-10-23
HUMATROPE 12 MG CARTRIDGE	00002-8148-01	1803.43000	EACH	2024-08-21
HUMATROPE 12 MG CARTRIDGE	00002-8148-01	1803.43000	EACH	2024-07-17
HUMATROPE 12 MG CARTRIDGE	00002-8148-01	1803.43000	EACH	2024-06-19
HUMATROPE 12 MG CARTRIDGE	00002-8148-01	1803.43000	EACH	2024-05-22

Market Analysis and Price Projections for Humatrope

Market Overview

Humatrope, a recombinant human growth hormone (rhGH) developed by Eli Lilly and Company, is a leading product in the global human growth hormone (hGH) market. Here’s a comprehensive look at the market dynamics, growth projections, and pricing trends for Humatrope.

Market Size and Growth Projections

The global hGH drugs market, which includes Humatrope, is expected to experience significant growth. From 2022 to 2030, the market is projected to grow from $3.5 billion to $4.8 billion, driven by increasing demand and innovative products[1][3].

Dominant Regions

North America and Europe are the dominant regions for the hGH market, with the U.S. market alone estimated at $1.4 billion in 2022. These regions are expected to maintain their strong market presence, although the Asia-Pacific region, particularly China, is forecast to witness the fastest growth with a CAGR of 5.8% over the analysis period[1][3].

Applications and Market Segments

Humatrope is used to treat various conditions, including growth hormone deficiency (GHD) in children and adults, Turner syndrome, idiopathic short stature, and Prader-Willi syndrome. The GHD application segment leads the market, with pediatric GHD being a significant sub-segment[1][3].

Route of Administration

The subcutaneous route of administration dominates the hGH drugs market, including Humatrope. This segment is projected to record a 4.5% CAGR and reach $3.1 billion by the end of the analysis period from 2022 to 2030[1].

Market Trends and Drivers

• High Prevalence of GHD: The increasing prevalence of growth hormone deficiency disorders is a key driver for the market. Growing awareness about GHD and its treatments is also boosting demand for products like Humatrope[1][3].
• Innovations in Long-Acting hGH Drugs: The development of long-acting hGH drugs is another significant driver. These drugs offer reduced frequency of administration, improved patient compliance, and convenience, which are augmenting segment uptake[3].

Challenges and Opportunities

• Emergence of Biosimilars: The expiry of patents for several hGH products, including potentially Humatrope, paves the way for the emergence of biosimilars. While this could erode revenue growth for branded products, it also presents opportunities for companies to develop biosimilar versions of their own products[1].
• High Cost of Treatment: The high cost of hGH treatments is a significant challenge. However, programs like discount cards and patient assistance can help mitigate this issue[5].

Financial Performance and Projections

While specific financial data for Humatrope is not provided, the overall financial trajectory of the hGH market is positive. The market's growth is driven by increasing demand, innovative products, and expanding geographic reach[1][3].

Pricing Trends

The cost of Humatrope can vary based on the dosage and the pharmacy. Here are some approximate prices for Humatrope injectable kits:

• 6 mg Injectable Kit: Around $989 for a supply of 1 kit[5].
• 12 mg Injectable Kit: Around $1,969 for a supply of 1 kit[5].
• 24 mg Injectable Kit: Around $3,929 for a supply of 1 kit[5].

These prices are for cash-paying customers and can be reduced using discount cards or patient assistance programs.

Cost Comparison with Other hGH Products

Humatrope is one of the more expensive options in the hGH market. For example, a pharmacoeconomic review indicates that Genotropin, another hGH product, could offer cost savings compared to Humatrope. At maximum doses, Genotropin would be cost-neutral or produce cost savings versus Humatrope, Nutropin, and Omnitrope, but would incur additional costs compared to Saizen[4].

Key Takeaways

• Market Growth: The global hGH drugs market is projected to grow from $3.5 billion in 2022 to $4.8 billion by 2030.
• Dominant Regions: North America and Europe are the leading regions, with the Asia-Pacific region showing the fastest growth.
• Key Drivers: High prevalence of GHD, growing awareness, and innovations in long-acting hGH drugs.
• Challenges: High cost of treatment, emergence of biosimilars, and complex delivery systems.
• Pricing: Humatrope is priced around $989 to $3,929 for different dosages, with potential cost savings through discount programs.

FAQs

Q: What is the projected market size for the global Human Growth Hormone (hGH) drugs market by 2030? A: The global hGH drugs market is projected to reach $4.8 billion by 2030[1].

Q: Which route of administration dominates the hGH drugs market? A: The subcutaneous route dominates the hGH drugs market, with a projected CAGR of 4.5% over the analysis period[1].

Q: What are the primary applications of Humatrope? A: Humatrope is used to treat growth hormone deficiency (GHD) in children and adults, Turner syndrome, idiopathic short stature, and Prader-Willi syndrome[1][3].

Q: How is the emergence of biosimilars affecting the hGH market? A: The emergence of biosimilars could erode revenue growth for branded products but also presents opportunities for companies to develop biosimilar versions of their own products[1].

Q: What are the key geographic markets for Humatrope and other hGH drugs? A: North America and Europe are the dominant regions, with the Asia-Pacific region, particularly China, showing significant growth potential[1][3].

Cited Sources

1. Drug Patent Watch - Humatrope
2. Market Research Intellect - Global Solvent Humatrope Market
3. Grand View Research - Human Growth Hormone Market Size & Share Report, 2030
4. Common Drug Review - Pharmacoeconomic Review Report: somatropin (Genotropin)
5. Drugs.com - Humatrope Prices, Coupons, Copay Cards & Patient Assistance